Dr. Reddys Laboratories (RDY)
(Delayed Data from NYSE)
$78.54 USD
+0.19 (0.24%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $78.52 -0.02 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Doctor Reddy's (RDY) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$82.17 | $92.00 | $67.50 | 4.88% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Doctor Reddy's comes to $82.17. The forecasts range from a low of $67.50 to a high of $92.00. The average price target represents an increase of 4.88% from the last closing price of $78.35.
Analyst Price Targets (3 )
Broker Rating
Doctor Reddy's currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 2.75 a month ago based on four recommendations.
Of the four recommendations deriving the current ABR, three are Strong Buy, representing 75% of all recommendations. A month ago, Strong Buy represented 50%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 1 |
Sell | 0 | 0 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.00 | 2.00 | 2.75 | 2.75 | 2.80 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/28/2024 | Not Identified | Not Identified | Moderate Sell | Strong Buy |
5/6/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 4 |
Average Target Price | $82.17 |
LT Growth Rate | 11.10% |
Industry | Medical - Generic Drugs |
Industry Rank by ABR | 38 of 253 |
Current Quarter EPS Est: | 0.99 |
RDY FAQs
Dr. Reddy's Laboratories Ltd (RDY) currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 4 brokerage firms.
The average price target for Dr. Reddy's Laboratories Ltd (RDY) is $82.17. The current on short-term price targets is based on 4 reports.
The forecasts for Dr. Reddy's Laboratories Ltd (RDY) range from a low of $67.5 to a high of $92. The average price target represents a increase of $4.62 from the last closing price of $78.54.
The current UPSIDE for Dr. Reddy's Laboratories Ltd (RDY) is 4.62%
Based on short-term price targets offered by three analysts, the average price target for Doctor Reddy's comes to $82.17. The forecasts range from a low of $67.50 to a high of $92.00. The average price target represents an increase of 4.88% from the last closing price of $78.35.